Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Soverini

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Medicine|December 2, 2020
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?Simona Soverini, Simona Bernardi, Sara Galimberti
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Molecular monitoring and mutations in chronic myeloid leukemia: how to get the most out of your tyrosine kinase inhibitorMichele Baccarani, Simona Soverini, Caterina De Benedittis
Expert Review of Anticancer Therapy|June 7, 2008
Imatinib mesylate for the treatment of chronic myeloid leukemiaSimona Soverini, Giovanni Martinelli, Ilaria Iacobucci, et al.
Current Hematologic Malignancy Reports|January 8, 2014
Molecular monitoringSimona Soverini, Gianantonio Rosti, Michele Baccarani, et al.
Nature Clinical Practice. Oncology|December 19, 2008
Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapyGiovanni Martinelli, Simona Soverini, Ilaria Iacobucci, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
New targets for Ph+ leukaemia therapyGiovanni Martinelli, Ilaria Iacobucci, Cristina Papayannidis, et al.
International Journal of Molecular Sciences|December 11, 2019
Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An UpdateLuana Bavaro, Margherita Martelli, Michele Cavo, et al.
Haematologica|May 10, 2007
Targeted therapy and the T315I mutation in Philadelphia-positive leukemiasSimona Soverini, Ilaria Iacobucci, Michele Baccarani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid LeukemiaSimona Soverini, Caterina de Benedittis, Manuela Mancini, et al.
The Oncologist|April 2, 2016
Best Practices in Chronic Myeloid Leukemia Monitoring and ManagementSimona Soverini, Caterina De Benedittis, Manuela Mancini, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Medicine|December 2, 2020
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?Simona Soverini, Simona Bernardi, Sara Galimberti
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Molecular monitoring and mutations in chronic myeloid leukemia: how to get the most out of your tyrosine kinase inhibitorMichele Baccarani, Simona Soverini, Caterina De Benedittis
Expert Review of Anticancer Therapy|June 7, 2008
Imatinib mesylate for the treatment of chronic myeloid leukemiaSimona Soverini, Giovanni Martinelli, Ilaria Iacobucci, et al.
Current Hematologic Malignancy Reports|January 8, 2014
Molecular monitoringSimona Soverini, Gianantonio Rosti, Michele Baccarani, et al.
Nature Clinical Practice. Oncology|December 19, 2008
Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapyGiovanni Martinelli, Simona Soverini, Ilaria Iacobucci, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
New targets for Ph+ leukaemia therapyGiovanni Martinelli, Ilaria Iacobucci, Cristina Papayannidis, et al.
International Journal of Molecular Sciences|December 11, 2019
Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An UpdateLuana Bavaro, Margherita Martelli, Michele Cavo, et al.
Haematologica|May 10, 2007
Targeted therapy and the T315I mutation in Philadelphia-positive leukemiasSimona Soverini, Ilaria Iacobucci, Michele Baccarani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid LeukemiaSimona Soverini, Caterina de Benedittis, Manuela Mancini, et al.
The Oncologist|April 2, 2016
Best Practices in Chronic Myeloid Leukemia Monitoring and ManagementSimona Soverini, Caterina De Benedittis, Manuela Mancini, et al.
Pageof 17